SEARCH RESULTS

24 RESULTS

Schneider Lon on PBT2 Takes a Dive in Phase 2 Alzheimer’s Trial

COMMENT The big picture here is that Prana’s only prior Phase 2 trial with PBT2 — completed in 2007 with 78 mild AD patients treated for 12 weeks — showed lower CSF Aβ42 and nominally significant effects on verbal fluency and working memory. A reasonable ...

Current Filters

  • TYPE: Comment x
  • Commentator: Schneider, Lon S x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE